ABSTRACT
INTRODUCTION: Polycythaemia vera patients can present with arterial or venous vascular occlusive events such as thrombosis or cardiovascular disease; disease-related symptoms may significantly impact on the quality of life. The aim of this study was to evaluate the efficacy and safety of erythrocytapheresis compared to phlebotomy in the treatment of polycythaemia patients. METHODS: This study reports the findings of a retrospective analysis of 40 polycythaemia vera patients diagnosed according to published guidelines and treated either with erythrocytapheresis or phlebotomy over a four-year period. The goal of treatment was to reduce blood volume and red blood cell count to near normal levels as both of which may attenuate the symptoms and complications associated with polycythaemia. Patients were treated by applying a mathematical model. RESULTS: Using the model, 28 erythrocytapheresis procedures were performed. Blood laboratory values (red blood cell count, haemoglobin count and haematocrit level) were significantly reduced in patients treated with erythrocytapheresis. Moreover, among treated patients, erythrocytapheresis resulted in less work absenteeism and reduced costs due to lost production, with a lower overall procedure cost in comparison to phlebotomy. CONCLUSION: This model can assist in selecting the proper treatment modality for individual patients. Especially for those with high blood volumes and high achievable haematocrit levels (delta), erythrocytapheresis offers a more efficient method in red blood cell depletion compared to phlebotomy thereby, potentially reducing the number of treatment procedures required for the induction of polycythaemia vera patients as well as the interval between procedures during the maintenance phase.
ABSTRACT
The objective of this study is to assess the effectiveness of non-immersive virtual reality as a pain-distraction measure in children between the ages of 3 and 5 years undergoing painful injection procedures in an outpatient setting. We carried out a randomized, unmasked clinical trial in children undergoing venipuncture or intramuscular injection procedures. Patients were randomized to a distraction virtual reality video or standard care. After the procedure, three independent observers (parents, researchers, nursing staff) rated pain on the LLANTO pain scale. We recruited 122 subjects, half of which were randomized to virtual reality. The median age was of approximately 60 months (IQR: 15 months), and the sample was balanced with regard to sex. There were significant differences in LLANTO scales scores between the VR subjects and controls of - 3.34 (95% CI - 4.15; - 2.54), - 3.02 (95% CI - 3.90; - 2.14), and - 2.98 (95% CI - 3.87; - 2.09), as rated by parents, researchers, and nursing staff, respectively. Agreement between raters was high for all three types of observers, with Cohen Kappas over 0.79 in all cases. Bivariate analysis showed reductions in the risk of obtaining higher scores in the LLANTO scale. Linear regression models showed a reduction of approximately 3 points in the scale, regardless of the type of observer. These models were adjusted for sex, age, kind of procedure, use of prior analgesia, and recruitment center. CONCLUSIONS: Non-immersive virtual reality is an effective adjunctive therapy for the reduction of pain in children undergoing painful injection procedures in an outpatient setting. This strategy may be used to improve the quality of care in pediatric outpatient services. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03985930 (Registered June 14, 2019). WHAT IS KNOWN: â¢The use of immersive virtual reality (VR) has been described as an effective adjunctive distraction method during painful procedures in children over 5 years. WHAT IS NEW: â¢The utility of non-immersive VR in children below that age is not yet clear. This randomized clinical trial comparing non-immersive VR vs. standard care showed an average reduction of three points in the LLANTO pain scale favoring non-immersive VR. Non-immersive VR is an effective and inexpensive non-pharmacological technique that reduces fear and pain in pediatric patients.
ABSTRACT
Resumo Hemocromatose hereditária (HH) é a doença genética mais comum em descendentes de europeus e sua epidemiologia em nosso país é incerta. Considerando o cenário das políticas públicas em HH no mundo contemporâneo, este artigo propõe uma reflexão sobre o tema, com objetivo de fazer uma revisão bibliográfica narrativa sobre a abordagem adotada para essa doença em países desenvolvidos e a nível nacional. Além disso, discute sobre o custo-benefício da incorporação do índice de saturação da transferrina (ST) e ferritina sérica (FS) no nosso sistema de saúde, com a finalidade de identificar a HH antes que surjam suas complicações, bem como seu rastreio em campanhas nacionais de prevenção. O valor gasto para o screening da HH com dosagem de ST e FS pelo Sistema Único de Saúde (SUS) é muito menor do que os custos gerados quando o dano por excesso de ferro já está estabelecido. Nos casos suspeitos de HH, deveria ser viabilizada pelo SUS a pesquisa da mutação genética para o gene HFE, que atualmente só está disponível de forma privada. Com essas medidas, modifica-se a história natural da doença, reduzindo a morbimortalidade dos portadores e custos ao sistema público de saúde.
Abstract Hereditary hemochromatosis (HH) is the most common genetic disease among European descendants and its epidemiology in Brazil is unclear. Considering the contemporary public policy scenario aimed at HH, this narrative bibliographic review reflects on the approach adopted for this disease at the national level in developed countries. It also discusses the cost-effectiveness of incorporating transferrin saturation (TS) and serum ferritin (SF) indexes in the Brazilian healthcare system for early HH identification, as well as its screening in national prevention campaigns. The amount spent on ST- and FS-based HH screening by the Brazilian National Health System (SUS) is much lower than the costs generated by the already established iron overload. In suspected cases, genetic mutation research of the HFE gene, which is currently only performed privately, should be made available by the SUS. These measures can modify the natural history, reducing HH morbidity and mortality and its costs to the public health system.
Subject(s)
Phlebotomy , Ferritins , Healthy AgingABSTRACT
BACKGROUND: Hemochromatosis is a genetic condition of iron overload caused by deficiency of hepcidin. In a previous stage of this study, patients with suspected hemochromatosis had their quality of life (QL) measured. We observed that QL scores differed among genotypic groups of patients. In this reported final phase of the study, the aims were to compare QL scores after a treatment period of approximately 3 years and to analyze a possible association of the serum ferritin values with QL scores. METHODS: Sixty-five patients were enrolled in this final phase and divided into group 1 (patients that showed primary iron overload and homozygous genotype for the HFE p.Cys282Tyr mutation) and group 2 (other kinds of genotypes). Short Form 36 (SF-36) was performed and consisted of eight domains with a physical and also a mental component. RESULTS: Both groups had a significant decrease in serum ferritin concentrations: group 1 had a variation from 1844 ± 1313 ng/mL to 281 ± 294 ng/mL, and group 2 had a variation from 1216 ± 631 ng/mL to 236 ± 174 ng/mL. Group 1 had a smaller mean value for these six SF-36 domains compared with group 2, indicating a worse QL. CONCLUSIONS: In this final stage, six domains demonstrated a difference among genotypic groups (role emotional and mental health, adding to the four of the initial phase), reassuring the impact of the identified genotype on the QL of hemochromatosis patients. Furthermore, despite that both patient groups demonstrated similar and significant decreases in serum ferritin values, no association was found between the decrease in this biological parameter and the SF-36 domains.
Subject(s)
Ferritins/blood , Hemochromatosis Protein/genetics , Hemochromatosis/diagnosis , Hemochromatosis/genetics , Membrane Proteins/genetics , Mutation , Quality of Life , Genetic Predisposition to Disease , Genotype , Hemochromatosis/blood , HumansABSTRACT
BACKGROUND: Reducing the blood-culture contamination rate is a constant challenge for health services. This study aimed to analyze whether blood-culture (BC) collection using sterile gloves reduces the contamination rate when compared to the non-sterile gloves, and to compare baseline and intervention periods. METHODS: A randomized clinical trial, performed in an intensive care unit in Brazil and paired in two groups: sterile (BCs obtained with modified sterile technique: only sterile gloves; no fenestrated drape or dedicated sterile collection kit) and clean (clean technique: usual care with non-sterile gloves). Two paired blood samples were obtained from each patient by trained and calibrated nurses. BCs were processed by conventional microbiological methods and the results were issued by blinded microbiologists. RESULTS: There was no difference (P = 1.00) in the contamination rate of BC between the sterile (1%) and clean (1%) groups. However, there was a significant difference (P = 0.05; relative risk: 0.17; 95% confidence interval: 0.04-0.70) in the contamination rate between baseline (6.1%; 20/330) and intervention (1%; 2/200). CONCLUSIONS: This study suggests that the aseptic care provided in obtaining samples is more important than the sterile technique itself, and highlights the value of standardizing the practices, qualification and calibration of phlebotomists.
Subject(s)
Drug Contamination , Equipment Contamination , Brazil , HumansABSTRACT
RESUMEN La hemocromatosis hereditaria (HH) consiste en una sobrecarga progresiva de hierro que conlleva a un acúmulo anormal del mismo en diferentes órganos blancos; y, que, en caso de no tratarse a tiempo, puede causar una disfunción multi-orgánica. Se han descrito diversas mutaciones genéticas asociadas a la HH, la más frecuente de ellas es la asociada al gen-HFE, la cual se encuentra en el 90% de los casos. En la actualidad la flebotomía terapéutica continúa siendo el tratamiento de elección para el manejo de esta patología. Reportamos el caso de un paciente en seguimiento por fibrosis hepática severa, con persistencia de un perfil ferrocinético elevado, a quien cinco años después se le diagnostica una HH no asociada a una mutación en el gen-HFE; recibió manejo con flebotomías periódicas, presentando rápidamente una mejoría significativa de su cuadro clínico y de los niveles de ferritina al igual que otros paraclínicos.
ABSTRACT Hereditary hemochromatosis (HH) consists of a progressive iron overload that leads to an abnormal accumulation of iron in different target organs; and, if not treated in time, can cause multi-organ dysfunction. Various genetic mutations associated with HH have been described, the most frequent is associated with the HFE-gene, which is found in 90% of cases. At present, therapeutic phlebotomy continues to be the treatment of choice for the management of this pathology. We report the case of a patient under follow-up for severe liver fibrosis, with persistence of a high ferrokinetic profile, who five years later was diagnosed with HH not associated to a mutation in the HFE-gene; He was managed with periodic phlebotomies, rapidly presenting a significant clinical improvement and decrease of ferritin levels.
ABSTRACT
Medical attention is not free from committing mistakes that can increase mortality and costs. The International Goals for Patient Safety include correct patient identification. The use of wristbands reduces the number of adverse events. The rate of nonidentified patients at the moment of phlebotomy was investigated retrospectively during 2019. The annual rate of non-identified patients was 9.8% and higher rates were observed from April to September. Monday was the day with the highest rate of non-identified. There was statistically significant relationship between the month rate of non-identified patients and the number of discharges from operative unit per month (r=0.6465; p=0.0237) and the bed turnover rate (r=0.7776; p=0.0029). Other wristband identification errors are unknown. The investigation detected failures in patient identification that allowed to make recommendations. In order to reduce the number of missing wristbands it will be necessary to monitor the indicator, especially during the months with the highest number of discharges and bed turnover rate, to evaluate the adherence of the personnel to the current protocol and to carry out training programs.
La atención médica no se encuentra libre de errores, que pueden poner en riesgo tanto la salud como la vida de los pacientes, con aumento de la morbimortalidad y los costos del sistema sanitario. Las recomendaciones internacionales de seguridad del paciente incluyen una correcta identificación. El uso de pulseras identificatorias reduce la cantidad de eventos adversos. Se investigó en forma retrospectiva la tasa de pacientes sin pulsera identificatoria al momento de la extracción sanguínea durante el año 2019 en el Instituto de Investigaciones Médicas Alfredo Lanari (IDIM). Se registró un total de 521 casos de pacientes no identificados sobre 5267 pedidos de laboratorio. La tasa anual de no identificados fue de 9.8%, superior al máximo ac eptable, y entre abril a septiembre se observaron mayores valores promedio. El día de la semana con mayor tasa de no identificados fueron los lunes con un 14%. Se observó una relación estadísticamente significativa entre la tasa mensual de no identificados con la cantidad mensual de egresos d e unidades operativas (r = 0.6465; p = 0.0237) y con el giro cama (r = 0.7776; p = 0.0029). Se desconoce si hubo otros errores de identificación. El estudio permitió conocer fallas en la identificación de pacientes internados. Se recomienda monitorear el indicador especialmente durante los meses con mayor cantidad de egresos y giro cama, evaluar la adherencia del personal al protocolo vigente y realizar capacitaciones para lograr una menor tasa de no identificados.
Subject(s)
Inpatients , Patient Identification Systems , Humans , Retrospective StudiesABSTRACT
BACKGROUND: Thrombotic events are well documented in primary erythrocytosis, but it is uncertain if secondary etiologies increase the risk of thrombosis. This study aimed to determine the causes of erythrocytosis and to identify its impact as a risk factor for thrombosis. METHODS: Data were obtained from patients with erythrocytosis between 2000 and 2017 at a referral hospital in Mexico City. Erythrocytosis was defined according to the 2016 WHO classification. Time to thrombosis, major bleeding, or death were compared among groups of patients defined by the etiology of erythrocytosis using a Cox regression model, adjusting for cardiovascular risk factors. RESULTS: In total, 330 patients with erythrocytosis were studied. The main etiologies of erythrocytosis were obstructive sleep apnea (OSA) in 29%, polycythemia vera (PV) in 18%, and chronic lung disease (CLD) in 9.4% of the patients. The incidence rate of thrombosis was significantly higher in patients with PV and CLD than that in patients with OSA (incidence rates of 4.51 and 6.24 vs. 1.46 cases per 100 person-years, P=0.009), as well as the mortality rate (mortality rates of 2.72 and 2.43 vs. 0.17 cases per 100 person-years, P =0.003). CONCLUSION: The risk of thrombosis in CLD with erythrocytosis was comparable to that in patients with PV. Further larger-scale studies are needed to confirm these findings and evaluate the benefits of preventive management of COPD with erythrocytosis similar to PV.
ABSTRACT
Resumen La atención médica no se encuentra libre de errores, que pueden poner en riesgo tanto la salud como la vida de los pacientes, con aumento de la morbimortalidad y los costos del sistema sanitario. Las recomendaciones internacionales de seguridad del paciente incluyen una correcta identificación. El uso de pulseras identificatorias reduce la cantidad de eventos adversos. Se investigó en forma retrospectiva la tasa de pacientes sin pulsera identificatoria al momento de la extracción sanguínea durante el año 2019 en el Instituto de Investigaciones Médicas Alfredo Lanari (IDIM). Se registró un total de 521 casos de pacientes no identificados sobre 5267 pedidos de laboratorio. La tasa anual de no identificados fue de 9.8%, superior al máximo ac eptable, y entre abril a septiembre se observaron mayores valores promedio. El día de la semana con mayor tasa de no identificados fueron los lunes con un 14%. Se observó una relación estadísticamente significativa entre la tasa mensual de no identificados con la cantidad mensual de egresos d e unidades operativas (r = 0.6465; p = 0.0237) y con el giro cama (r = 0.7776; p = 0.0029). Se desconoce si hubo otros errores de identificación. El estudio permitió conocer fallas en la identificación de pacientes internados. Se recomienda monitorear el indicador es pecialmente durante los meses con mayor cantidad de egresos y giro cama, evaluar la adherencia del personal al protocolo vigente y realizar capacitaciones para lograr una menor tasa de no identificados.
Abstract Medical attention is not free from committing mistakes that can increase mortality and costs. The International Goals for Patient Safety include correct patient identification. The use of wristbands reduces the number of adverse events. The rate of non-identified patients at the moment of phlebotomy was investigated retrospectively during 2019. The annual rate of non-identified patients was 9.8% and higher rates were observed from April to September. Monday was the day with the highest rate of non-identified. There was statistically significant relationship between the month rate of non-identified patients and the number of discharges from operative unit per month (r=0.6465; p=0.0237) and the bed turnover rate (r=0.7776; p=0.0029). Other wristband identification errors are unknown. The investigation detected failures in patient identification that allowed to make recommendations. In order to reduce the number of missing wristbands it will be necessary to monitor the indicator, especially during the months with the highest number of discharges and bed turnover rate, to evaluate the adherence of the personnel to the current protocol and to carry out training programs.
Subject(s)
Humans , Patient Identification Systems , Inpatients , Retrospective StudiesABSTRACT
In the clinical laboratory, knowledge of and the correct use of clot activators and anticoagulant additives are critical to preserve and maintain samples in optimal conditions prior to analysis. In 2017, the Latin America Confederation of Clinical Biochemistry (COLABIOCLI) commissioned the Latin American Working Group for Preanalytical Phase (WG-PRE-LATAM) to study preanalytical variability and establish guidelines for preanalytical procedures to be applied by clinical laboratories and health care professionals. The aim of this critical review, on behalf of COLABIOCLI WG-PRE-LATAM, is to provide information to understand the mechanisms of the interactions and reactions that occur between blood and clot activators and anticoagulant additives inside evacuated tubes used for laboratory testing. Clot activators - glass, silica, kaolin, bentonite, and diatomaceous earth - work by surface dependent mechanism whereas extrinsic biomolecules - thrombin, snake venoms, ellagic acid, and thromboplastin - start in vitro coagulation when added to blood. Few manufacturers of evacuated tubes state the type and concentration of clot activators used in their products. With respect to anticoagulant additives, sodium citrate and oxalate complex free calcium and ethylenediaminetetraacetic acid chelates calcium. Heparin potentiates antithrombin and hirudin binds to active thrombin, inactivating the thrombin irreversibly. Blood collection tubes have improved continually over the years, from the glass tubes containing clot activators or anticoagulant additives that were prepared by laboratory personnel to the current standardized evacuated systems that permit more precise blood/additive ratios. Each clot activator and anticoagulant additive demonstrates specific functionality, and both manufacturers of tubes and laboratory professional strive to provide suitable interference-free sample matrices for laboratory testing. Both manufacturers of in vitro diagnostic devices and laboratory professionals need to understand all aspects of venous blood sampling so that they do not underestimate the impact of tube additives on laboratory testing.
Subject(s)
Anticoagulants , Blood Specimen Collection , Anticoagulants/pharmacology , Blood Coagulation , Humans , PhlebotomyABSTRACT
La hemocromatosis hereditaria es una enfermedad que se caracteriza por la sobrecarga sistémica de hierro y se asocia a múltiples mutaciones genéticas que conducen a una producción inadecuadamente baja de la hormona hepcidina o a una alteración en la unión de la hepcidina a la ferroportina. Esto tiene como resultado un aumento de la absorción intestinal y el depósito de cantidades excesivas de hierro en las células, lo cual, a su vez, si no se corrige, genera daño tisular. La expresión clínica puede variar desde individuos completamente asintomáticos, hasta pacientes con cirrosis hepática a temprana edad, y eventualmente carcinoma hepatocelular. Habitualmente, el diagnóstico no es invasivo e incluye el examen clínico, la evaluación de los parámetros de hierro plasmático, imágenes y pruebas genéticas. El principal tratamiento es la flebotomía, pero terapias alternativas como la suplementación con hepcidina son un tema de investigación actual.
Hereditary hemochromatosis is a disease characterized by systemic iron overload of genetic origin, that leads to an inadequately low production of the hormone hepcidin or a reduction in hepcidinferroportin binding. This results in an increased intestinal absorption and the deposit of excessive amounts of iron in cells, which in turn results in tissue damage if not treated. The clinical expression can vary from completely asymptomatic individuals, to patients with liver cirrhosis at an early age, and eventually hepatocellular carcinoma. Diagnosis is usually noninvasive and includes clinical examination, assessment of plasma iron levels, imaging studies, and genetic testing. The main medical treatment is phlebotomy, but alternative therapies such as hepcidin supplementation are the subject of current research.
Subject(s)
Humans , Hemochromatosis , Phlebotomy , Hemochromatosis Protein , Liver CirrhosisABSTRACT
BACKGROUND: Cannulation of a peripheral venous access is a routine procedure in pediatric patients admitted to the hospital. 50% of the time cannulation on the first attempt is not feasible, so it is necessary to repeat the puncture, resulting in a complex and frustrating procedure. Half of the children admitted to the hospital have a difficult venous access (DIVA). OBJECTIVE: To carry out a review, which provides information about DIVA in pediatrics, how to evaluate and proceed in these patients. DESIGN: DIVA Score considers vein palpability, vein visibility, age and history of prematurity. The score ranges from 0 to 10 points. Values greater than 4 are associated with difficult venous access. There are associated risk factors: obesity, musculoskeletal malformations, chemotherapy treatment, diabetes mellitus, patients on dialysis, limb edema, moderate to severe dehydration, history of difficult venous access, anxiety of the patient and/or parents report that the child is less likely to cooperate. When making the decision to establish a venous access, it should be evaluated whether it is an emergency or not, the characteristics of the medications and infusions, the time of therapy and the anatomical sites for puncture. Ultrasound and transillumination techniques decrease the time to obtain a venous access and increase the success rate on the first attempt. CONCLUSION: The decision to obtain a venous access must take into account the criteria and risk factors for DIVA. The most recognized scale is the DIVA Score.
INTRODUCCIÓN: La canulación de un acceso venoso periférico es un procedimiento rutinario en los pacientes pediátricos que ingresan al hospital. 50% de las veces la canulación al primer intento es frustra, por lo que es necesario repetir la punción resultando el procedimiento complejo y frustrante. La mitad de los niños que ingresa al hospital presentan un acceso venoso difícil (DIVA, sigla derivada de "difficult intravenous access"). OBJETIVO: Realizar una revisión, que entrega información acerca de DIVA en pediatría, cómo evaluar y proceder en estos pacientes. DESARROLLO: DIVA Score considera palpabilidad y visibilidad venosa, edad y antecedente de prematurez. El puntaje va desde 0 a 10 puntos. Valores mayores a 4 se asocian a acceso venoso difícil. Existen factores de riesgo asociados: obesidad, malformaciones osteomusculares, tratamiento con quimioterapia, diabetes mellitus, pacientes en diálisis, edema de extremidades, deshidratación moderada a severa, historia de acceso venoso difícil, ansiedad del paciente y/o padres que refieren que el niño es poco probable que coopere. Al tomar la decisión de establecer un acceso venoso se debe evaluar si es urgencia o no, las características de los medicamentos e infusiones, tiempo de terapia y los sitios anatómicos para punción. La ultrasonografía y las técnicas de transiluminación disminuyen el tiempo de obtención del acceso venoso e incrementan la tasa de éxito en el primer intento. CONCLUSIÓN: En la decisión de obtener un acceso venoso se deben tener en cuenta los criterios y factores de riesgo de acceso venoso difícil. La escala más reconocida es el DIVA Score.
Subject(s)
Humans , Child , Catheterization, Peripheral/adverse effects , Catheterization, Peripheral/standards , Ultrasonography, Interventional , Decision Making , Administration, IntravenousABSTRACT
Introducción. La anemia es una complicación para los recién nacidos de muy bajo peso al nacer, y los exámenes de laboratorio son un factor de riesgo preponderante. Más del 50 % recibe, al menos, una transfusión de glóbulos rojos. Estas se han asociado a mayor riesgo de infecciones, hemorragia intracraneal, enterocolitis necrotizante y displasia broncopulmonar. En 2012, se implementó, en el Hospital Italiano de Buenos Aires, una estrategia de menor volumen de extracción de sangre por flebotomía. El objetivo del presente estudio fue evaluar su asociación con el número detransfusiones.Métodos. Estudio cuasiexperimental del tipo antes/después. Se comparó el número de transfusiones entre dos grupos de prematuros de muy bajo peso con diferente volumen de extracción. Se evaluó la correlación entre el volumen extraído y el número de transfusiones estimando el coeficiente de Spearman. Para ajustar por confundidores, se realizó un modelo de regresión logística.Resultados. Se incluyeron en el estudio 178 pacientes con edad gestacional media de 29,4 semanas (desvío estándar: 2,7) y peso al nacer de 1145 gramos (875-1345). El perfil de la serie roja inicial fue similar entre ambos grupos. El número de transfusiones (p = 0,017) y el volumen transfundido (p = 0,048) disminuyeron significativamente. El coeficiente de correlación resultó de 0,83. En el análisis multivariado, volumen de extracción y peso al nacer se asociaron a un requerimiento mayor de 3 transfusiones.Conclusión. Un menor volumen de extracción de sangre en prematuros de muy bajo peso está asociado de manera independiente a menor requerimiento transfusional.
Introduction. Anemia is a complication in very low birth weight (VLBW) infants, and lab tests are a predominant risk factor. At least one red blood cell transfusion is given in more than 50 % of cases. Transfusions are associated with a higher risk for infections, intracranial hemorrhage, necrotizing enterocolitis, and bronchopulmonary dysplasia. In 2012, Hospital Italiano de Buenos Aires implemented a strategy to collect a lower blood volume by phlebotomy. The objective of this study was to assess its association with the number of transfusions.Methods. Before-and-after, quasi-experimental study. The number of transfusions was compared between two groups of VLBW preterm infants with different blood collection volumes. The correlation between the collection volume and the number of transfusions was assessed estimating Spearman's coefficient. A logistic regression model was used to adjust for confounders.Results. The study included 178 patients with a mean gestational age of 29.4 weeks (standard deviation: 2.7) and a birth weight of 1145 g (875-1345). The baseline red series profile was similar between both groups. The number of transfusions (p = 0.017) and the transfusion volume (p = 0.048) decreased significantly. The correlation coefficient was 0.83. In the multivariate analysis, collection volume and birth weight were associated with a requirement of more than three transfusions.Conclusion. A lower blood collection volume in VLBW preterm infants is independently associated with fewer transfusion requirements.
Subject(s)
Humans , Male , Female , Infant, Newborn , Blood Volume , Erythrocyte Transfusion , Phlebotomy/adverse effects , Infant, Premature , Infant, Very Low Birth Weight , Erythrocyte Indices , Non-Randomized Controlled Trials as Topic , Anemia, Neonatal/prevention & control , Anemia, Neonatal/therapyABSTRACT
INTRODUCTION: Anemia is a complication in very low birth weight (VLBW) infants, and lab tests are a predominant risk factor. At least one red blood cell transfusion is given in more than 50 % of cases. Transfusions are associated with a higher risk for infections, intracranial hemorrhage, necrotizing enterocolitis, and bronchopulmonary dysplasia. In 2012, Hospital Italiano de Buenos Aires implemented a strategy to collect a lower blood volume by phlebotomy. The objective of this study was to assess its association with the number of transfusions. METHODS: Before-and-after, quasi-experimental study. The number of transfusions was compared between two groups of VLBW preterm infants with different blood collection volumes. The correlation between the collection volume and the number of transfusions was assessed estimating Spearman's coefficient. A logistic regression model was used to adjust for confounders. RESULTS: The study included 178 patients with a mean gestational age of 29.4 weeks (standard deviation: 2.7) and a birth weight of 1145 g (875-1345). The baseline red series profile was similar between both groups. The number of transfusions (p = 0.017) and the transfusion volume (p = 0.048) decreased significantly. The correlation coefficient was 0.83. In the multivariate analysis, collection volume and birth weight were associated with a requirement of more than three transfusions. CONCLUSION: A lower blood collection volume in VLBW preterm infants is independently associated with fewer transfusion requirements.
Introducción. La anemia es una complicación para los recién nacidos de muy bajo peso al nacer, y los exámenes de laboratorio son un factor de riesgo preponderante. Más del 50 % recibe, al menos, una transfusión de glóbulos rojos. Estas se han asociado a mayor riesgo de infecciones, hemorragia intracraneal, enterocolitis necrotizante y displasia broncopulmonar. En 2012, se implementó, en el Hospital Italiano de Buenos Aires, una estrategia de menor volumen de extracción de sangre por flebotomía. El objetivo del presente estudio fue evaluar su asociación con el número de transfusiones. Métodos. Estudio cuasiexperimental del tipo antes/después. Se comparó el número de transfusiones entre dos grupos de prematuros de muy bajo peso con diferente volumen de extracción. Se evaluó la correlación entre el volumen extraído y el número de transfusiones estimando el coeficiente de Spearman. Para ajustar por confundidores, se realizó un modelo de regresión logística. Resultados. Se incluyeron en el estudio 178 pacientes con edad gestacional media de 29,4 semanas (desvío estándar: 2,7) y peso al nacer de 1145 gramos (875-1345). El perfil de la serie roja inicial fue similar entre ambos grupos. El número de transfusiones (p = 0,017) y el volumen transfundido (p = 0,048) disminuyeron significativamente. El coeficiente de correlación resultó de 0,83. En el análisis multivariado, volumen de extracción y peso al nacer se asociaron a un requerimiento mayor de 3 transfusiones. Conclusión. Un menor volumen de extracción de sangre en prematuros de muy bajo peso está asociado de manera independiente a menor requerimiento transfusional.
Subject(s)
Anemia/etiology , Erythrocyte Transfusion/statistics & numerical data , Infant, Premature, Diseases/etiology , Infant, Very Low Birth Weight , Phlebotomy/adverse effects , Phlebotomy/methods , Anemia/therapy , Female , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/therapy , Logistic Models , Male , Risk Factors , Treatment OutcomeABSTRACT
Objetivo: avaliar as alterações do potássio em relação a frequência de aperto de punho pelos participantes da pesquisa, buscando contribuir para um melhor entendimento sobre os aspectos quantitativos em relação ao uso da técnica de aperto de punho durante a flebotomia, para verificar com que frequência o aperto de punho poderá contribuir para a elevação do potássio. Método: Foram realizadas duas coletas sanguíneas de cada indivíduo. Em um primeiro momento, mantendo as mãos relaxadas durante flebotomia e, segundo, bombeando o punho durante o procedimento de flebotomia para avaliar as alterações do potássio em relação a frequência de aperto de punho. Resultados: De um modo geral, observa-se que houveram alterações em praticamente todas as dosagens e que indivíduos poderiam ter sido diagnosticados incorretamente com uma hipercalemia, podendo ser submetidos a tratamentos desnecessários. Conclusão: A técnica de aperto de punho durante a flebotomia deve ser evitada, pois uma significativa porcentagem dos casos apresentou uma elevação de potássio não condizente com o nível sérico de potássio normal do indivíduo.
Objective: To evaluate potassium alterations in relation to wrist grip frequency by the research participants, seeking to contribute to a better understanding of the quantitative aspects regarding the use of wrist grip technique during phlebotomy, to verify how often wrist may contribute to potassium elevation. Method: Two blood samples were collected from each individual. At first, keeping the hands relaxed during phlebotomy and secondly, pumping the fist clenching the phlebotomy procedure to evaluate potassium changes in relation to the frequency of wrist tightening. Results: In general, it was observed that there were changes in practically all dosages and that individuals could have been misdiagnosed with hyperkalemia and could be submitted to unnecessary treatments. Conclusion: The technique of wrist tightening during phlebotomy should be avoided, since a significant percentage of the cases presented a potassium elevation that does not correspond to the individual's normal serum potassium level.
Subject(s)
PotassiumABSTRACT
SUMMARY INTRODUCTION Iron overload is a broad syndrome with a large spectrum of causative etiologies that lead to iron deposition. When iron exceeds defenses, it causes oxidative damage and tissular disfunction. Treatment may prevent organ dysfunction, leading to greater life expectancy. METHODS Literature from the last five years was reviewed through the use of the PubMed database in search of treatment strategies. DISCUSSION Different pharmacological and non-pharmacological strategies are available for the treatment of iron overload and must be used according to etiology and patient compliance. Therapeutic phlebotomy is the basis for the treatment of hereditary hemochromatosis. Transfusional overload patients and those who cannot tolerate phlebotomy need iron chelators. CONCLUSION Advances in the understanding of iron overload have lead to great advances in therapies and new pharmacological targets. Research has lead to better compliance with the use of oral chelators and less toxic drugs.
RESUMO INTRODUÇÃO A síndrome de sobrecarga de ferro engloba um grande espectro de etiologias que levam a um aumento da quantidade de ferro nos tecidos. Esse ferro excede a capacidade de proteção dos tecidos, levando a dano oxidativo e lesão tissular. Tratamento pode prevenir esse dano, levando à melhor sobrevida. METODOLOGIA A literatura dos últimos cinco anos foi revisada por meio de pesquisa na base de dados PubMed buscando identificar estratégias de tratamento. DISCUSSÃO Medidas farmacológicas e não farmacológicas estão disponíveis para o tratamento da síndrome de sobrecarga de ferro e devem ser utilizadas de acordo com a etiologia e a aceitação do paciente. A flebotomia terapêutica é base do tratamento dos pacientes com hemocromatose hereditária. Pacientes com sobrecarga transfusional ou aqueles que não toleram flebotomias devem utilizar quelantes de ferro. CONSIDERAÇÕES FINAIS Avanços no entendimento da síndrome de sobrecarga de ferro têm levado a grandes progressos na terapêutica, com promessas de abordagem de novos alvos farmacológicos. A evolução da pesquisa tem possibilitado melhor aderência com o uso de quelantes orais e com possibilidade de drogas menos tóxicas.
Subject(s)
Humans , Iron Chelating Agents/therapeutic use , Iron Overload/therapy , Syndrome , Patient Compliance , Phlebotomy/methods , Hemochromatosis/therapyABSTRACT
A sangria terapêutica é um procedimento hemoterápico de simples realização, eficaz quando indicada corretamente. Atualmente, as principais doenças que se beneficiam com este tratamento são as hiperferritinemias e as eritrocitoses. O presente estudo teve como objetivo principal conhecer o perfil dos pacientes submetidos à sangria terapêutica em um consultório privado de hematologia, localizado na região sul de Santa Catarina. Trata-se de estudo observacional e retrospectivo, com análise quantitativa de dados secundários. Todos os 113 pacientes identificados compuseram a amostra final. As indicações de sangria mais prevalentes foram hiperferritinemia secundária (46,9%) e hiperferritinemia com mutação do gene HFE (44,2%). A média de idade dos pacientes foi de 53,12 anos, sendo a maioria composta por homens (84,1%), todos da raça branca, e 31% procedentes de Criciúma. Destes pacientes, 77,9% realizaram estudo genético, o qual mostrou 56,8% positivos para hiperferritinemia com mutação do gene HFE, 6,8% para o gene da policitemia vera e 36,4% com resultado negativo. Ao comparar os índices laboratoriais antes e após a sangria terapêutica, observouse redução estatisticamente significativa nos valores de ferritina sérica e saturação de transferrina nos casos de hiperferritinemia com mutação do gene HFE e de ferritina sérica para hiperferritinemia secundária. Conclui-se que o perfil dos pacientes submetidos à sangria terapêutica na região sul de Santa Catarina, no período estudado, é composto principalmente por homens, acima de 50 anos de idade, e que a indicação mais prevalente para o tratamento são as sobrecargas de ferro.
Therapeutic bloodletting is a haemotherapic procedure of easy execution and effective when indicated correctly. Currently, the main diseases that benefit from this treatment are the iron overload syndromes and erythrocytosis. The main objective of this study was to know the profile of patients submitted to bloodletting therapy in a private hematology practice, located in the southern region of Santa Catarina. It is an observational and retrospective study with quantitative analysis of secondary data. All the 113 patients identified have composed the final sample. The most prevalent phlebotomy indications were secondary iron overload (46.9%) and iron overload with mutation of the HFE gene (44.2%). The average age of the patients was 53.12 years, most of which were men (84.1%), all of the white race and 31.0% of Criciúma. Of these patients, 77.9% performed genetic study, being 56.8% positive for iron overload with mutation of the HFE gene, 6.8% for the polycythemia vera gene and 36.4% showed negative result. By comparing the laboratory indices before and after the therapeutic bloodletting, significant reduction was observed in the values of serum ferritin and transferrin saturation in the iron overload with mutation of the HFE gene cases. About secondary iron overload, it was observed significant reduction only in serum ferritin. It's concluded that the profile of patients who are submitted to therapeutic bloodletting in the southern region of Santa Catarina, in the studied period, is composed mainly of men, above 50 years of age and the most prevalent indication for treatment are the iron overloads.
ABSTRACT
BACKGROUND: We analyze the effects of water ingestion before blood extraction on routine hematological parameters. METHODS: Twenty female volunteers -mean 24 y- were included. Blood was collected after a 12â¯h fast period (T0) and 1â¯h after the ingestion of 300â¯ml water (T1). These parameters were analyzed: white blood cell (WBC) count; WBC differential count including lymphocytes (LYM), monocytes (MONO), neutrophils, eosinophils (EOS), and basophils; red blood cell (RBC) count; hematocrit (HCT); hemoglobin (HGB); mean cell volume; mean cell hemoglobin; RBC distribution width; and platelet count (PLT). Statistical significance: Pâ¯<â¯0.05. Mean difference % (MD%) was calculated for each parameter and was compared with reference change value (RCV). A change was considered clinically significant when MD% exceeded the RCV. RESULTS: Significant differences were observed in (medians, T0 vs T1, P): WBC ×109/l (6.51 vs 6.12, 0.002); LYM ×109/l (2.90 vs 2.19, 0.000); MONO ×109/l (0.50 vs 0.48, 0.031); EOS ×109/l (0.17 vs 0.16, 0.003); RBC ×1012/l (4.46 vs 4.40, 0.024); HCT l/l (0.38 vs 0.37, 0.036); HGB g/l (129 vs 129, 0.009). All MDs% were lower than their respective RCV. CONCLUSION: Ingestion of 300â¯ml water 1â¯h before blood extraction does not alter the hematological parameters studied.
Subject(s)
Drinking , Fasting/blood , Hematologic Tests/methods , Pre-Analytical Phase , Water/pharmacology , Adult , Artifacts , Cohort Studies , Female , Humans , Young AdultABSTRACT
Introducción. El uso de simuladores de pacientes humanos es una estrategia eficaz en la enseñanza de procedimientos clínicos. Sin embargo, existe poca información para ayudar a los profesores a mejorar sus estrategias docentes permitiéndoles mejorar las experiencias de aprendizaje de acuerdo a la edad o el sexo de los alumnos que emplean este tipo de simulación. Objetivos. Identificar si existen diferencias por sexo o edad en asociación a las habilidades de los alumnos del primer semestre de medicina para la flebotomía. Diseño. Cuasiexperimental. Lugar. Centro de Simulación Médica Montagne de la Universidad Marista de Mérida. Participantes. Estudiantes de primer semestre de la licenciatura en medicina. Intervenciones. Intervención educativa del proceso de flebotomía con toma de muestra, empleando simuladores de alta fidelidad. Para el análisis, se evaluó la asociación de las variables de edad y sexo con el desempeño de los alumnos. Principales medidas de los resultados. Se analizaron las evaluaciones prácticas y teóricas. Para la evaluación práctica se aplicó una rúbrica de 20 ítems y se promediaron las puntuaciones de las esferas teóricas y prácticas de los alumnos. Resultados. Se identificó que las mujeres desempeñaron mejor sus habilidades prácticas (p<0,03) aún en el modelo de regresión lineal ajustado por edad y grupo. Discusión. El mejor desempeño en la práctica de flebotomía entre las alumnas de medicina difícilmente sea un hallazgo aislado, pues puede derivarse de las habilidades para la comunicación interpersonal, misma que también puede ser reforzada en los alumnos del sexo masculino.
Introduction. The use of human patient simulators is an effective strategy in the teaching of clinical procedures. However, there is little information to help teachers improve their teaching strategies, allowing them to improve learning experiences according to the age or sex of students who use this type of simulation. Objectives. To identify if there are differences by sex or age in association with the skills of the students of the first semester of medicine for phlebotomy. Design. Quasiexperimental. Places. Medical Simulation Centre Montagne of the Marista University of Merida. Participants. First semester medical students. Interventions. Educational intervention of the phlebotomy process with sample taking, and using high fidelity simulators. For the analysis, sociodemographic variables were associated with the performance of the students. Main result measures. The practical and theoretical evaluations were analyzed. For the practical evaluation, a rubric of 20 items was applied and the scores of the theoretical and practical areas of the students were averaged. Results. It was identified that women performed their practical skills better (p <0.03) even in the linear regression model adjusted for age and group. Discussion. The best performance in the practice of phlebotomy among medical students is hardly an isolated finding, since they could derive from the skills for interpersonal communication, which can also be reinforced in male students.
ABSTRACT
BACKGROUND: The multifaceted clinical laboratory process is divided in three essential phases: the preanalytical, analytical and postanalytical phase. Problems emerging from the preanalytical phase are responsible for more than 60% of laboratory errors. This report is aimed at highlighting and discussing nonconformity (e.g., nonstandardized procedures) in primary blood tube mixing immediately after blood collection by venipuncture with evacuated tube systems. METHODS: From January 2015 to December 2015, fifty different laboratory quality managers from Brazil were contacted to request their internal audit reports on nonconformity regarding primary blood tube mixing immediately after blood collection by venipuncture performed using evacuated tube systems. RESULTS AND CONCLUSIONS: A minority of internal audits (i.e., 4%) concluded that evacuated blood tubes were not accurately mixed after collection, whereas more than half of them reported that evacuated blood tubes were vigorously mixed immediately after collection, thus magnifying the risk of producing spurious hemolysis. Despite the vast ma jority of centers declaring that evacuated blood tubes were mixed gently and carefully, the overall number of inversions was found to be different from that recommended by the manufacturer. Since the turbulence generated by the standard vacuum pressure inside the primary evacuated tubes seems to be sufficient for providing solubilization, mixing and stabilization between additives and blood during venipuncture, avoidance of primary tube mixing probably does not introduce a major bias in tests results and may not be considered a nonconformity during audits for accreditation.